UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055909
Receipt number R000063883
Scientific Title Development of the Revised motivation for rehabilitation scale (MORE scale-R)
Date of disclosure of the study information 2024/10/22
Last modified on 2024/10/22 10:35:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of the Revised motivation for rehabilitation scale (MORE scale-R)

Acronym

Development of the Revised motivation for rehabilitation scale (MORE scale-R)

Scientific Title

Development of the Revised motivation for rehabilitation scale (MORE scale-R)

Scientific Title:Acronym

Development of the Revised motivation for rehabilitation scale (MORE scale-R)

Region

Japan


Condition

Condition

cerebrovascular disease, musculoskeletal disease, etc.
The diseases eligible for admission to the convalescent rehabilitation wards.

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To develop a scale that can assess the motivation of participants undergoing rehabilitation for various diseases and disease stages, and to verify the characteristics of the scale.

Basic objectives2

Others

Basic objectives -Others

Scale Characteristic Validation

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

MORE Scale - R Score

Key secondary outcomes

Psychopsychological assessment scores (e.g., Apathy scale, Self-rating depression scale)
Motivation assessment (e.g., pre-revision MORE scale)
Basic information on the participants (age, gender, disease, medical history, motor-cognitive function, and life function should be referred to from the medical record)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Participants receiving rehabilitation at the facility where the study is being conducted, such as inpatient, outpatient, or long-term care insurance service.
Participants who have given informed consent for this study.

Key exclusion criteria

Participants who have difficulty in understanding the content of the assessment items and answering each item of the questionnaire due to cognitive decline or higher brain dysfunction.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Yohei
Middle name
Last name Otaka

Organization

Fujita Health University School of Medicine

Division name

Department of Rehabilitation Medicine

Zip code

470-1192

Address

1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi

TEL

0562-93-2167

Email

otaka119@mac.com


Public contact

Name of contact person

1st name Taiki
Middle name
Last name Yoshida

Organization

Fujita Health University

Division name

Faculty of Rehabilitation, School of Health Sciences

Zip code

470-1192

Address

1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi

TEL

0562-93-9000

Homepage URL


Email

taiki.yoshida@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee of Fujita Health University

Address

1-98 Dengakugakubo, Kutukake-cho, Toyoake, Aichi

Tel

0562-93-2865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

藤田医科大学病院(愛知県),藤田医科大学七栗記念病院(三重県),東京湾岸リハビリテーション病院(千葉県),済生会守山市民病院(滋賀県)


Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 07 Month 08 Day

Date of IRB

2024 Year 07 Month 08 Day

Anticipated trial start date

2024 Year 07 Month 08 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To develop a scale that can assess the motivation of participants undergoing rehabilitation for various diseases and disease stages, and to verify the characteristics of the scale.


Management information

Registered date

2024 Year 10 Month 22 Day

Last modified on

2024 Year 10 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063883